Literature DB >> 21068742

Androgenetic/biparental mosaicism in a girl with Beckwith-Wiedemann syndrome-like and upd(14)pat-like phenotypes.

Kazuki Yamazawa1, Kazuhiko Nakabayashi, Kentaro Matsuoka, Keiko Masubara, Kenichiro Hata, Reiko Horikawa, Tsutomu Ogata.   

Abstract

This report describes androgenetic/biparental mosaicism in a 4-year-old Japanese girl with Beckwith-Wiedemann syndrome (BWS)-like and paternal uniparental disomy 14 (upd(14)pat)-like phenotypes. We performed methylation analysis for 18 differentially methylated regions on various chromosomes, genome-wide microsatellite analysis for a total of 90 loci and expression analysis of SNRPN in leukocytes. Consequently, she was found to have an androgenetic 46,XX cell lineage and a normal 46,XX cell lineage, with the frequency of the androgenetic cells being roughly calculated as 91% in leukocytes, 70% in tongue tissues and 79% in tonsil tissues. It is likely that, after a normal fertilization between an ovum and a sperm, the paternally derived pronucleus alone, but not the maternally derived pronucleus, underwent a mitotic division, resulting both in the generation of the androgenetic cell lineage by endoreplication of one blastomere containing a paternally derived pronucleus and in the formation of the normal cell lineage by union of paternally and maternally derived pronuclei. It appears that the extent of overall (epi)genetic aberrations exceeded the threshold level for the development of BWS-like and upd(14)pat-like phenotypes, but not for the occurrence of other imprinting disorders or recessive Mendelian disorders.

Entities:  

Mesh:

Year:  2010        PMID: 21068742     DOI: 10.1038/jhg.2010.142

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

1.  Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy.

Authors:  Jennifer M Kalish; Laura K Conlin; Tricia R Bhatti; Holly A Dubbs; Mary Catherine Harris; Kosuke Izumi; Sogol Mostoufi-Moab; Surabhi Mulchandani; Sulagna Saitta; Lisa J States; Daniel T Swarr; Alisha B Wilkens; Elaine H Zackai; Kristin Zelley; Marisa S Bartolomei; Kim E Nichols; Andrew A Palladino; Nancy B Spinner; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2013-06-26       Impact factor: 2.802

2.  Genome-wide uniparental diploidy of all paternal chromosomes in an 11-year-old girl with deafness and without malignancy.

Authors:  Irena Borgulová; Inna Soldatova; Martina Putzová; Marcela Malíková; Jana Neupauerová; Simona Poisson Marková; Marie Trková; Pavel Seeman
Journal:  J Hum Genet       Date:  2018-04-10       Impact factor: 3.172

3.  Genome-wide paternal uniparental disomy mosaicism in a woman with Beckwith-Wiedemann syndrome and ovarian steroid cell tumour.

Authors:  Magdalena Gogiel; Matthias Begemann; Sabrina Spengler; Lukas Soellner; Ulf Göretzlehner; Thomas Eggermann; Gertrud Strobl-Wildemann
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

Review 4.  Kagami-Ogata syndrome: a clinically recognizable upd(14)pat and related disorder affecting the chromosome 14q32.2 imprinted region.

Authors:  Tsutomu Ogata; Masayo Kagami
Journal:  J Hum Genet       Date:  2015-09-17       Impact factor: 3.172

5.  Parthenogenetic mosaicism: generation via second polar body retention and unmasking of a likely causative PER2 variant for hypersomnia.

Authors:  Yohei Masunaga; Masayo Kagami; Fumiko Kato; Takeshi Usui; Takako Yonemoto; Kazuo Mishima; Maki Fukami; Kazushi Aoto; Hirotomo Saitsu; Tsutomu Ogata
Journal:  Clin Epigenetics       Date:  2021-04-07       Impact factor: 6.551

6.  Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndrome.

Authors:  Tomoko Fuke; Seiji Mizuno; Toshiro Nagai; Tomonobu Hasegawa; Reiko Horikawa; Yoko Miyoshi; Koji Muroya; Tatsuro Kondoh; Chikahiko Numakura; Seiji Sato; Kazuhiko Nakabayashi; Chiharu Tayama; Kenichiro Hata; Shinichiro Sano; Keiko Matsubara; Masayo Kagami; Kazuki Yamazawa; Tsutomu Ogata
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.